Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Current Leases (2019 - 2025)

Sanofi (SNY) has disclosed Current Leases for 7 consecutive years, with $316.6 million as the latest value for Q4 2025.

  • Quarterly Current Leases rose 13.52% to $316.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $316.6 million through Dec 2025, up 13.52% year-over-year, with the annual reading at $307.3 million for FY2025, 8.79% up from the prior year.
  • Current Leases hit $316.6 million in Q4 2025 for Sanofi, up from $278.9 million in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $316.6 million in Q4 2025 to a low of $278.9 million in Q4 2024.
  • Historically, Current Leases has averaged $296.3 million across 5 years, with a median of $295.9 million in 2023.
  • Biggest five-year swings in Current Leases: decreased 8.16% in 2022 and later rose 13.52% in 2025.
  • Year by year, Current Leases stood at $307.7 million in 2021, then decreased by 8.16% to $282.6 million in 2022, then grew by 4.7% to $295.9 million in 2023, then dropped by 5.74% to $278.9 million in 2024, then increased by 13.52% to $316.6 million in 2025.
  • Business Quant data shows Current Leases for SNY at $316.6 million in Q4 2025, $278.9 million in Q4 2024, and $295.9 million in Q4 2023.